Covid-19 Ivermectin

Ytbnd · 30. jul 2021

Zakaj negativna pristranskost uradnih inštitucij glede ivermektina?

Vsi, ki se ukvarjamo z znanostjo, zelo dobro vemo, da obstaja pozitivna pristranskost (positive bias) in negativna pristranskost (negative bias) pri objavljanju znanstvenih člankov v posameznih aka…

damijan.org

SamSvoj · 30. jul 2021

Uporabnik mosseero je napisal:
Laž. Priporočene doze niso enako kot pri zajedalcih. Doze so bistveno višje. Pa še to doziranje predlaga neuradna zasebna iniciativa brez pooblastil. Kot bi jaz predlagal doziranje

Poleg tega ima MrDaco prav. Ivermectin je zdravilo, ne preprečuje okužb, ampak morda omeji podvajanje virusa v zgodnji fazi okužbe. S tem korda preprečuje težji potek. Kaj je res, bomo izvedeli po končanih kliničnih testih. AndY1-jevi grafi padanja okužb zaradi ivermectina so totalen bullshit.

Evo sem si vzel par minut in sem šel preverjat. Priporočena doza pri zgodnjem kovidu je tako kot je napisal Andy, 0,2 mg do izboljšanja oz. pet dni po priporočilih AFD - America's Frontline Doctors - recimo, ostalih nisem niti iskal (slika spodaj).
Priporočene doze za živali (in recimo za garje pri ljudeh - to sem našel, naprej nisem iskal) so enake - 200 mikrogramov
Link za garje https://www.nijz.si/sites/www.nijz.si/files/datoteke/garje_zdravljenje_pripombe_dermatologi_2019.pdf

Boš zdaj ti pokazal zakaj praviš da je to laž?

Se pa da razpravljat koliko so AFD neuradna in nepooblaščena organizacija. No, so. Ampak jim bi vseeno bolj zaupal kot tebi. Brez zamere....

mosseero · 1. avg 2021

Približno toliko so uradni kot "slovenski zdravniki". Zakaj pa bi moral zaupati meni? Zaupati je treba uradnim ustanovam, ki sledijo predpisanim postopkom. Ko bojo uradni rezultati kliničnih testov, sej naj stvar vpelje v protokol. Prej pa nima kaj iskati v postopku zdravljenja.

johan_blond · 2. avg 2021

Najnovejši (relevanten) pregled zaključenih študij o ivermecrinu.

Sklep: dosedanje študije ne potrjujejo učinkovitosti ivermectina.

Based on the current very low‐ to low‐certainty evidence, we are uncertain about the efficacy and safety of ivermectin used to treat or prevent COVID‐19. The completed studies are small and few are considered high quality. Several studies are underway that may produce clearer answers in review updates. Overall, the reliable evidence available does not support the use ivermectin for treatment or prevention of COVID‐19 outside of well‐designed randomized trials.

https://doi.org/10.1002/14651858.CD015017.pub2

Janez40 · 2. avg 2021

Uporabnik johan_blond je napisal:
Najnovejši (relevanten) pregled zaključenih študij o ivermecrinu.

Sklep: dosedanje študije ne potrjujejo učinkovitosti ivermectina.

Based on the current very low‐ to low‐certainty evidence, we are uncertain about the efficacy and safety of ivermectin used to treat or prevent COVID‐19. The completed studies are small and few are considered high quality. Several studies are underway that may produce clearer answers in review updates. Overall, the reliable evidence available does not support the use ivermectin for treatment or prevention of COVID‐19 outside of well‐designed randomized trials.

https://doi.org/10.1002/14651858.CD015017.pub2

Kot sem že enkrat napisal. Če bodo študije pokazale, da je to čudežno zdravilo, bo Andy skakal po levi trepalnici od zadovoljstva. Če pa bodo študije pokazale, da zadeva ni učinkovita, bo pa vpil, da je vse zarota in limal grafe Indije ali kakšne druge vukojebine do onemoglosti.

Da bi imel promil samo spoštovanja ali inteligence in celo izjavil "my bad", očitno res ni tako učinkovit, kot je kazalo in gremo dalje, se ne bo zgodilo nikoli.

sad · 2. avg 2021

Če jaz prav berem piše, da je potrebno počakati na zaključek bolj relevantnih študij.
Si zelo podoben Andyu, le da vpiješ drugo skrajnost. Vsaj preberi in razumi, ne pa da delaš končne zaključke na podlagi študij, kjer jasno piše, da se počaka. Ali si na poti YT doktorata?

jest5 · 2. avg 2021

Ti za začetek slabo bereš, kaj je napisal

sad · 2. avg 2021

No, dej ti preberi njegov zadnji stavek. Vidim, da vas več YT doktorate dela.

jest5 · 2. avg 2021

Sem ga. Daj ga tudi ti. Lahko tudi 10x ponoviš. Probaj počasi in neprizadeto

sad · 2. avg 2021

Uporabnik jest5 je napisal:
Sem ga. Daj ga tudi ti. Lahko tudi 10x ponoviš. Probaj počasi in neprizadeto

No, dej mi povej, zakaj naj bi Andy izjavljal MY BAD, če zaključki študije NISO dokončni. No, razloži. Hvala.
Pa se njegovim neumnostim samo smejim in si ne morem predstavljati, da odrasel in razumen človek take poka, ampak zapis zgoraj od janeza je praktično na njegovem nivoju.
Za razliko od janeza (ki je očitno že prepričan, da ivermectin ne pomaga) si pa jaz želim, da bi študije pokazale, da ivermectin res pomaga, pa čeprav bi potem bral tukaj samospeve andyija nad njegovo pametjo. Bom pa počakal na kvalitetne študije, da vidimo ali res pomaga ali ne.

jest5 · 2. avg 2021

Uporabnik sad je napisal:
No, dej mi povej, zakaj naj bi Andy izjavljal MY BAD, če zaključki študije NISO dokončni. No, razloži. Hvala.
Pa se njegovim neumnostim samo smejim in si ne morem predstavljati, da odrasel in razumen človek take poka, ampak zapis zgoraj od janeza je praktično na njegovem nivoju.
Za razliko od janeza (ki je očitno že prepričan, da ivermectin ne pomaga) si pa jaz želim, da bi študije pokazale, da ivermectin res pomaga, pa čeprav bi potem bral tukaj samospeve andyija nad njegovo pametjo. Bom pa počakal na kvalitetne študije, da vidimo ali res pomaga ali ne.

Še parkrat bo potrebno prebrati.
Pa poizkusi za spremembo s celotnim postom.
Jaz vidim besede, kot so "bodo", "bo"
Ne pa "je".

sad · 2. avg 2021

Ok, ne da se mi več.

Spajky · 2. avg 2021

Tudi jest citruse pomaga kot preventiva za Korono :evil:

Hesperidin and SARS-CoV-2: New Light on the Healthy Function of Citrus Fruits

Among the many approaches to Coronavirus disease 2019 (COVID-19) prevention, the possible role of nutrition has so far been rather underestimated. Foods are very rich in substances, with a potential beneficial effect on health, and some of these could have an antiviral action or be important in...

www.mdpi.com

AndY1 · 2. avg 2021

Epidemiologic Analyses on Ivermectin in COVID-19

The Latest Results of Ivermectin’s Success in Treating Outbreaks of COVID-19 including charts and data by Juan Chamie.

covid19criticalcare.com

The New York Times COVID “Mystery” solved!
Cases have plunged in India in a few weeks. True
The New York Times reported on July 30, 2021, that this is a mystery with no clear explanation. But, the drop in cases happened right after a new COVID-19 protocol was released in India. The new guideline includes Ivermectin for early treatment — to treat patients with mild symptoms.

Analiza vsebuje tudi druge drzave, kjer je bil uporabljen Ivermectin.

AndY1 · 3. avg 2021

GPs Start Prescribing Low-Dose Ivermectin Triple Therapy for COVID-19

GPs Start Prescribing Low-Dose Ivermectin Triple Therapy for COVID-19 Sydney, Australia – Australian triple therapy specialist Professor Thomas Borody, internationally famous for curing peptic ulcers using a triple antibiotic therapy saving thousands

prwire.com.au

AndY1 · 4. avg 2021

Favorable outcome on viral load and culture viability using Ivermectin in early treatment of non-hospitalized patients with mild COVID-19 – A double-blind, randomized placebo-controlled trial

Background Ivermectin, an anti-parasitic agent, also has anti-viral properties. Our aim was to assess whether ivermectin can shorten the viral shedding in patients at an early-stage of COVID-19 infection. Methods The double-blinded trial compared patients receiving ivermectin 0·2 mg/kg for 3...

www.medrxiv.org

Favorable outcome on viral load and culture viability using Ivermectin in early treatment of non-hospitalized patients with mild COVID-19 – A double-blind, randomized placebo-controlled trial
Conclusions There were significantly lower viral loads and viable cultures in the ivermectin group, which could lead to shortening isolation time in these patients.

AndY1 · 4. avg 2021

Israeli scientist says COVID-19 could be treated for under $1/day

Double-blind study shows ivermectin reduces disease’s duration and infectiousness • FDA and WHO caution against its use

m.jpost.com

Prof. Eli Schwartz, founder of the Center for Travel Medicine and Tropical Disease at Sheba, conducted a randomized, controlled, double-blinded trial from May 15, 2020, through the end of January 2021 to evaluate the effectiveness of ivermectin in reducing viral shedding among nonhospitalized patients with mild to moderate COVID-19.

mcn · 5. avg 2021

johan_blond · 6. avg 2021

AndY1, imaš novega favorita ali je to še vedno ivermectin

A giant trial of COVID-19 treatments is restarting. Here are the drugs it’s betting on

Solidarity, a global study led by the World Health Organization (WHO), will test three new drugs in hospitalized COVID-19 patients: the cancer drug imatinib, an antibody named infliximab that is used to treat autoimmune diseases, and artesunate, an antimalarial.

Artesunate, an injected derivative of artemisinin and a powerful killer of malaria parasites, has also shown some antiviral activity in laboratory studies of SARS-CoV-2. But Solidarity is testing it because of another effect: The drug appears to reduce inflammation and counteract signals that attract immune cells into tissues. That could stop the immune reactions that damage the lungs in severe COVID-19.

Science | AAAS

www.sciencemag.org

CLIO15 · 6. avg 2021

To ne velja ker je predrago in je konstrukt BIGpharme.

Po imenih sodeč sta vsaj 1 dva biološka zdravila ??

Imam prav?

Covid-19 Ivermectin

Guru

Majstr

fizik´alc

Guru

Guru

Guru

Guru

Guru

Guru

Guru

Guru

Guru

Guru

Guru

The New York Times COVID “Mystery” solved!​

Guru

Guru

Favorable outcome on viral load and culture viability using Ivermectin in early treatment of non-hospitalized patients with mild COVID-19 – A double-blind, randomized placebo-controlled trial​

Guru

Majstr

Guru

Guru

Podobne teme

The New York Times COVID “Mystery” solved!

Favorable outcome on viral load and culture viability using Ivermectin in early treatment of non-hospitalized patients with mild COVID-19 – A double-blind, randomized placebo-controlled trial